Počet záznamov: 1
cilostazol
SYS d000077407 LBL 00000nx^^^2200181-^^45^^ 005 20240119195328.8 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a cilostazol $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2019 (1985) $8 eng 330 1-
$a A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke. $8 eng 450 $a OPC 13013 $5 e $8 slo 450 $a Pletal $5 e $8 slo 450 $a 6-(4-(1-cyklohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-chinolinón $5 e $8 slo 686 $a D03.383.129.617.293 686 $a D03.633.100.810.069 750 $a Cilostazol $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190410 980 $x M
Počet záznamov: 1